Home | Welcome to Contract Pharma   
Last Updated Friday, December 19 2014

Print

Novasep Names Synthesis BU President



By Kristin Brooks



Published January 16, 2014
Related Searches: CMO contractpharma Manufacturing Development
Thierry Van Nieuwenhove has been appointed president of Novasep’s Synthesis Business Unit in Pompey, France. Mr. Van Nieuwenhove joins the company from Ajinomoto-Omnichem, a European synthetic molecules custom manufacturing organization, where he held positions as director, and general manager and member of the board. His experience includes driving business unit growth, leading global teams including sales and business development, R&D, supply chain and purchasing, as well as mergers and acquisitions.
 
“We are thrilled to welcome Thierry to Novasep as president of the Synthesis Business Unit,” said Michel Spagnol, chief executive officer of Novasep. “His broad experience in driving multicultural custom synthesis businesses will complement our COMEX skills perfectly. Thierry possesses the dynamics to boost Novasep’s CMO business in all our key markets.”
 


blog comments powered by Disqus

Receive free Contract Pharma Direct emails
Sign up now to receive the weekly newsletter, and more!

Enter your email address:
Follow Contract Pharma On